Learn how to safely check supplement-drug interactions using verified databases like NatMed. Step-by-step guide for clinicians to prevent dangerous adverse events and improve patient safety.
The time you take your medication can reduce side effects and boost effectiveness. Learn how chronotherapy uses your body’s natural rhythms to make drugs safer and more powerful.
The Hatch-Waxman Act of 1984 balanced drug innovation and generic access. It created the ANDA pathway, patent term restoration, and Paragraph IV challenges. Today, generics make up 90% of prescriptions but only 18% of spending. Learn how this law works and its ongoing challenges.
Learn how to safely clear expired medications by checking expiration dates and lot numbers against FDA recalls. Avoid dangerous errors with step-by-step protocols used by pharmacies.
The Orange Book is the FDA's official guide to therapeutic equivalence between brand-name and generic drugs. It tells pharmacists which generics can be safely swapped, saving billions in healthcare costs while ensuring patient safety.
Kombucha contains trace alcohol that can interact dangerously with medications like metronidazole, antidepressants, and diabetes drugs. Learn what levels are safe, which brands are risky, and how to protect yourself.
Automated refills for generic medicines help patients stick to their treatment by removing the hassle of manual requests. Learn how they work, their benefits, risks, and how to use them safely with online pharmacies.
Learn how to check the prescriber and pharmacy details on your medication label to prevent dangerous errors. Simple steps can stop wrong drugs, incorrect dosages, and life-threatening mix-ups.
Generics aren't just cheaper - they're often better for health outcomes. Learn how outcomes economics proves that generic medications improve adherence, reduce hospitalizations, and save billions - without sacrificing effectiveness.
Generic drugs are cheap because of competition, not government price controls. Learn how the U.S. keeps generics affordable through faster approvals, antitrust enforcement, and market incentives - not price caps.